Schedule 13G ownership disclosure

Alto Neuroscience Inc

Common Stock, par value $0.0001 per share · CUSIP: 02157Q109

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Point72 Asset Management, L.P.

    Shares: 1,692,153.00 · Class: 6.3%

  • Point72 Capital Advisors, Inc.

    Shares: 1,692,153.00 · Class: 6.3%

  • Point72 Biotech Private Investments, LLC

    Shares: 667,778.00 · Class: 2.5%

  • Differentiated Ventures Investments, LLC

    Shares: 667,778.00 · Class: 2.5%

  • 72 Investment Holdings, LLC

    Shares: 667,778.00 · Class: 2.5%

  • Steven A. Cohen

    Shares: 2,359,931.00 · Class: 8.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-001014
Form type
SCHEDULE 13G/A
Filer
Alto Neuroscience, Inc.
CIK
CIK 1999480
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub